| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Andrew D Lipman last filed a Form 4 in May 2024, as Director at NUS. Andrew D Lipman's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Andrew D Lipman's trades have earned a strong insider score of 85/100 across 30 rated trades. Over a 12-month horizon, all 30 of those trades were profitable, with an average 12-month return of +48.1%.
At the last filing, the largest reported position was 23,225 shares of NUS. The NUS filings lean toward selling, a net 89,400 shares.
Andrew D Lipman has 48 Form 4 filings on record from May 2015 to May 2024, all as Director at Nu Skin Enterprises (NUS), 2015–2024.
The 60 reported transactions were 31 open-market sales, 9 stock awards, 9 option exercises and 9 tax withholdings, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 31 sales worth about $3.5M.
The largest open-market sale was 30,000 shares of NUS at an average $64.13 on September 22, 2016, about $1.9M.
None of the 15 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from May 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 28, 2024 | NUS Nu Skin Enterprises, Inc. | Director | Sell | 2,000 | $13.33 | $26,660.00 | -7.9% | -24.6% | -44.5% | |
| Apr 25, 2024 | NUS Nu Skin Enterprises, Inc. | Director | Sell | 2,000 | $12.34 | $24,680.00 | -7.3% | -16.0% | -52.9% | |
| Mar 25, 2024 | NUS Nu Skin Enterprises, Inc. | Director | Sell | 2,000 | $12.32 | $24,640.00 | -6.8% | -7.9% | -45.2% | |
| Feb 26, 2024 | NUS Nu Skin Enterprises, Inc. | Director | Sell | 2,000 | $12.46 | $24,920.00 | -6.4% | +8.2% | -34.5% | |
| Jan 25, 2024 | NUS Nu Skin Enterprises, Inc. | Director | Sell | 2,000 | $18.55 | $37,100.00 | -6.0% | -34.2% | -63.7% | |
| Dec 26, 2023 | NUS Nu Skin Enterprises, Inc. | Director | Sell | 2,000 | $19.39 | $38,780.00 | -5.7% | -35.0% | -64.6% | |
| Nov 27, 2023 | NUS Nu Skin Enterprises, Inc. | Director | Sell | 2,000 | $17.11 | $34,220.00 | -5.4% | -26.0% | -55.4% | |
| Nov 3, 2023 | NUS Nu Skin Enterprises, Inc. | Director | Sell | 15,400 | $17.68 | $272,272.00 | -29.3% | +4.9% | -64.8% | |
| Oct 25, 2023 | NUS Nu Skin Enterprises, Inc. | Director | Sell | 2,000 | $19.23 | $38,460.00 | -3.7% | -5.4% | -67.5% | |
| Sep 25, 2023 | NUS Nu Skin Enterprises, Inc. | Director | Sell | 2,000 | $23.02 | $46,040.00 | -3.5% | -15.6% | -69.6% |